APUS
Financials
- Market Capitalization 11.17 M
- Employee 7
- Founded 2020
- CEO N/A
- Website www.apimedsus.com
- Headquarter Delaware, United States
- FIGI BBG01Q0T3D78
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4516 |  QCLS Q/C Technologies, Inc. - Common Stock | 3.45 USD | +0.58% | -4.43% | -15.85% | -23.33% | 27.09 M USD | ||
| 4607 |  MDCX Medicus Pharma Ltd. - Common Stock | 0.36 USD | -2.70% | -16.28% | +12.50% | -69.49% | 20.40 M USD | ||
| 4875 |  KAPA Kairos Pharma, Ltd. Common Stock | 0.36 USD | +5.88% | -2.70% | -20.00% | -37.93% | 7.71 M USD | ||
| 5029 |  PPCB Propanc Biopharma, Inc. - Common Stock | 1.63 USD | +1.87% | -7.91% | -25.23% | -59.25% | 3.71 M USD |
Frequently asked questions about Apimeds Pharmaceuticals US, Inc. Common Stock
What is the Apimeds Pharmaceuticals US, Inc. Common Stock stock price today?
The current price of Apimeds Pharmaceuticals US, Inc. Common Stock (APUS) is 0.74. Over the past 24 hours, the stock has changed by 0.00%. Follow the APUS chart for real-time price dynamics.
What is the stock ticker of Apimeds Pharmaceuticals US, Inc. Common Stock?
Apimeds Pharmaceuticals US, Inc. Common Stock trades under the ticker APUS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Apimeds Pharmaceuticals US, Inc. Common Stock stock going up?
APUS has changed by -1.33% over the last week, -42.19% over the last month, and -43.51% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Apimeds Pharmaceuticals US, Inc. Common Stock net income for the last quarter?
Apimeds Pharmaceuticals US, Inc. Common Stock reported net income of -35.06 M for the last quarter. The previous quarter showed -1.16 M, which means net income changed by -2934.72%.
How many employees does Apimeds Pharmaceuticals US, Inc. Common Stock have?
As of the latest available data, Apimeds Pharmaceuticals US, Inc. Common Stock has 7 employees. Workforce size can provide additional context about the company's scale and operations.
What is Apimeds Pharmaceuticals US, Inc. Common Stock EBITDA?
Apimeds Pharmaceuticals US, Inc. Common Stock EBITDA is -12.17 M, and its EBITDA margin is -2.63 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Apimeds Pharmaceuticals US, Inc. Common Stock stock?
You can buy Apimeds Pharmaceuticals US, Inc. Common Stock (APUS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Apimeds Pharmaceuticals US, Inc. Common Stock stock?
Investing in Apimeds Pharmaceuticals US, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the APUS chart and related analysis on metatrader.com as part of your research.